The approval of perpetual futures contracts in the US may expose traders to unforeseen tax and regulatory uncertainty, as the classification of these contracts as either swaps or futures remains unresolved, warns CME Group Chairman and CEO Terry Duffy. In an interview, Duffy emphasized the ambiguity surrounding the tax implications of these contracts, stating that there is a consequence that nobody is discussing.
The issue stems from the legal definition of swaps versus futures, with Duffy arguing that perpetual futures should be considered swaps due to the periodic funding payments exchanged between long and short positions. This classification could lead to a different tax treatment, with gains and losses potentially being taxed as ordinary income rather than receiving the blended tax treatment available under Section 1256 of the US tax code. However, legal experts caution that the issue is complex, with the definition of swaps being extremely broad and the economic function of perpetual futures resembling that of traditional futures.
The outcome of the ongoing legal battle between CME and the Commodity Futures Trading Commission (CFTC) may ultimately determine the tax treatment of these contracts, but the process is expected to be lengthy and litigious, with the potential for significant implications for market participants.